ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · IEX Real-Time Price · USD
8.65
+0.44 (5.36%)
Apr 23, 2024, 2:12 PM EDT - Market open

ARS Pharmaceuticals Revenue

In the year 2023, ARS Pharmaceuticals had annual revenue of $30.00K, a decrease of -97.72%.

Revenue (ttm)
$30.00K
Revenue Growth
-97.72%
P/S Ratio
28,081.97
Revenue / Employee
$1,250
Employees
24
Market Cap
835.70M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202330.00K-1.29M-97.72%
Dec 31, 20221.32M-4.19M-76.10%
Dec 31, 20215.51M--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Paragon 28 216.39M
National Research 148.58M
BioLife Solutions 143.27M
REGENXBIO 90.24M
Sage Therapeutics 86.46M
Nurix Therapeutics 80.89M
Tango Therapeutics 36.53M
Relay Therapeutics 25.55M
Revenue Rankings